n acetylcysteine with glutathione - Antioxidant & Mucolytic Agent N-Acetylcysteine (NAC) 500 mg |

Users who purchase from SWISS Pharmaceuticals typically do so because they want confidence in the quality of the ingredients and the trustworthiness of the manufacturing process

Several key factors contribute to post-COVID IBS development: Persistent viral components in gut mucosa for months after infection Profound alterations in microbiota composition with depletion of beneficial bacteria Compromised intestinal barrier integrity leading to bacterial translocation HPA axis dysregulation stemming from pandemic-related psychological stress Iatrogenic dysbiosis from antibiotics and other COVID-19 treatments Though no COVID-specific treatment protocols exist yet, clinicians must adapt established IBS management strategies

For individuals who have experienced immunogenic reactions to other therapeutic proteins or peptides, AOD-9604s demonstrated lack of immunogenicity may represent a favorable characteristic

Andersen, Frederik

Send your inquiry directly to us